Student Support

Carolina Within Reach

"We see you, we believe in you, we trust you, and you’re doing great things,” Dr. Bonifacio said.

"We see you, we believe in you, we trust you, and you’re doing great things,” Dr. Bonifacio said.

Laura Bonifacio ’03, ’05 (Pharm.D.), ’10 (Ph.D.) knows how important scholarship support can be. She received several scholarships during her time as a student.

Now, through the Carolina Annual Pharmacy Scholarship Program, she is enabling current students to follow her in her footsteps.

“Even beyond the dollars, there’s a huge impact on the students. You are creating a connection with those students. You are saying to them: ‘We see you, we believe in you, we trust you, and you’re doing great things,’” Dr. Bonifacio said.

UNC Eshelman School of Pharmacy Funding Priorities

    Explore More Stories

    A group shot of Owen Fenton and his team in the Fenton Lab
    Faculty Support

    Attracting Expertise

    Owen Fenton sees coming to Carolina as a win for his research interests.

    Tim Willson stands with arms crossed with lab equipment in the background.
    Faculty Support

    Bringing the dark proteome into the light

    A Q&A with Tim Willson, the inaugural Harold Kohn Distinguished Professor in Open Science Drug Discovery

    A UNC Eshelman School of Pharmacy student takes notes during class.
    Health

    Strengthening Diversity, Improving Care

    Grants to the UNC Eshelman School of Pharmacy will support diversity and rural care programs.

    Nate Hathaway in the CRISPR Screening Facility
    Research

    UNC-Chapel Hill Awarded Funding for Study of Malan Syndrome

    UNC Eshelman School of Pharmacy and CRISPR Screening Facility collaborate on Malan Syndrome study.

    Health

    Smarter Organ Transplants

    The UNC Eshelman Institute for Innovation's Venture Studio invested in technology for smarter organ transplants.

    Shawn Hingtgen and Jillian Perry
    Research

    Treating the Untreatable

    New research funded by a NIH grant seeks to combat one of the most treatment-resistant cancers